Kymera Therapeutics Inc : Oppenheimer Initiates Coverage With Outperform Rating and Target Price $53
Kymera Therapeutics Inc:奧本海默以跑贏大盤的評級和目標價53美元啓動保險
Kymera Therapeutics Inc : Oppenheimer Initiates Coverage With Outperform Rating and Target Price $53
Kymera Therapeutics Inc:奧本海默以跑贏大盤的評級和目標價53美元啓動保險
使用瀏覽器的分享功能,分享給你的好友吧